EWAS Open Platform 2026: a deeply integrated resource for epigenome-wide association studies
Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1061-D1068
DOI: 10.1093/nar/gkaf1155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.11.2025. Verfasst von Fei Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China. Hauptthemen laut MEDLINE: Epigenome, Genome-Wide Association Study, Software, Epigenomics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Epigenome-wide association studies (EWAS) has become an indispensable approach for elucidating the epigenetic basis of complex traits. EWAS Open Platform (https://ngdc.cncb.ac.cn/ewas/) includes three main components: EWAS Atlas (curated associations from publications), EWAS Data Hub (normalized DNA methylation array data), and EWAS Toolkit (one-stop analysis services). Here, we present a new release of EWAS Open Platform with the following significant updates and enhancements: (i) Expanded information: EWAS Atlas houses over 800 000 associations and incorporates an additional 17 000 curated causal relationships. EWAS Data Hub contains >180 000 batch-corrected samples, which incorporate data from newly added Illumina MethylationEPIC v2.0 BeadChip (935K) as well as trait-specific methylation profiles. EWAS Toolkit now provides an online batch correction tool and an interactive epigenetic causal network. (ii) Enhanced interoperability: data, knowledge, and toolkit are fully interconnected through a unified retrieval, offering integrated summaries and visualization capabilities. (iii) Artificial intelligence (AI)-based service: the platform is newly equipped with an AI-assisted question-answering service, allowing users to interactively explore EWAS-related questions and generate tailored insights. Taken together, EWAS Open Platform has undergone a significant upgrade across data resources, analytical tools, and service functionalities, offering more advanced support for unraveling complex molecular mechanisms from an epigenomic perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
- Interdisciplinary Institute for Medical Engineering, Fuzhou University, Fuzhou 350002, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Fei Yang, Wenting Zong, Bixia Tang, Dong Zou, Zhang Zhang, Rujiao Li
Förderung
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Yang, F., Xiong, Z., Zong, W., Kong, D., Tang, B., Chen, X., Wei, Y., Yu, X., Zhang, Y., Zou, D., Zhang, Z., Bao, Y., & Li, R. (2026). EWAS Open Platform 2026: a deeply integrated resource for epigenome-wide association studies. Nucleic Acids Research, 54(D1), D1061-D1068. https://doi.org/10.1093/nar/gkaf1155
Vancouver
Yang F, Xiong Z, Zong W, Kong D, Tang B, Chen X, et al. EWAS Open Platform 2026: a deeply integrated resource for epigenome-wide association studies. Nucleic Acids Research. 2026;54(D1):D1061-D1068. doi:10.1093/nar/gkaf1155
BibTeX
@article{Yang2026,
author = {Yang, Fei and Xiong, Zhuang and Zong, Wenting and Kong, Demian and Tang, Bixia and Chen, Xupeng and Wei, Yaoke and Yu, Xiangyu and Zhang, Yiran and Zou, Dong and Zhang, Zhang and Bao, Yiming and Li, Rujiao},
title = {EWAS Open Platform 2026: a deeply integrated resource for epigenome-wide association studies},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {D1},
pages = {D1061--D1068},
doi = {10.1093/nar/gkaf1155}
}
EUVIMED